Targeting all human proteins
Webinar: “Exploring neural lineages with brain organoids and their implications for understanding health and disease”
Discover the Power of Mini-Brains: Cerebral Organoids and their Impact on Understanding Health and Disease! A webinar hosted by Atlas Antibodies a specialist in antibodies for Neuroscience!
You are welcome to reserve your spot for our webinar.
Use a 10% discount with our promo code on FIRST purchaseGet a promo code
Selection of our highly validated primary antibodies
Atlas Antibodies is the original manufacturer of highly validated primary antibodies and control antigens.
For each product we share the antigen sequence, validation details, protocols, interspecies reactivity, references and related products.
Get promo code with a 10% discount on first purchase and reach your goals with our highly validated primary antibodies.
Neural Lineage Development Markers
A better comprehension of neuronal lineages is essential to our understanding of the nervous system and how it develops and functions in health and disease.
Atlas Antibodies manufactures primary polyclonal and monoclonal antibodies targeting relevant markers in the neural lineage development pathways such as: E-cadherin/CDH1, FABP7/BLBP, EOMES/TBR2, DCX, RBFOX3/NeuN, and many more.
Download NEW white paper>>>
Discover primary antibodies for neuroscience research on neuroinflammation, glioma, cortical layers, neural stem cells, and more.
Discover primary antibodies for cancer research, including oncology biomarkers, EMT markers, breast cancer, and colorectal cancer markers.
Discover primary antibodies for cell biology research, including organelle markers, integrin markers, and laminin markers.
Discover primary antibodies for stem cell research, including embryonal, neural and mesenchymal stem cell markers.
Our products in action
Our Anti-SOX6 in Parkinson's Disease Study
Our anti-GFAP in Alzheimer’s disease study
Our anti-TRPV2 in skin cancer research
Our anti-DMD in colorectal cancer research
Our anti-ZBTB18 helps to understand the mechanisms regulating metastasis
Six of our polyclonals in kidney cancer research
Our anti-SFXN4 in ovarian cancer therapy
Our Polyclonal Anti-HOPX Antibody in embryonic lung development research
Company and Events
Gavin Wood and Christian Eberle join Atlas Antibodies’ Board of Directors
Dr. Stefan Schmidt new CEO of evitria
Let’s meet at EACR 2023 in Turin on 12-15 June
Atlas Antibodies has new Chair of the Board Åsa Riisberg
Peter Ulvskjold steps in as interim CEO for the Atlas Antibodies Group
Free webinar: „Importance of reliable antibodies in tumor pathology: focus on gynecological pathology”
Atlas Antibodies supports the development of a new technique
Triple A Polyclonals
Triple A Polyclonals™ are rabbit polyclonals developed within the Human Protein Atlas project and made available to the scientific community by Atlas Antibodies. The antibodies are validated on all major tissues and organs in the human body. There are 500 staining images to look at for each antibody to facilitate your decision.
PrecisA Monoclonals™ are mouse monoclonals developed against several carefully selected target proteins. We select clones recognizing unique non-overlapping epitopes and/or isotypes. PrecisA Monoclonals are epitope mapped with defined specificity and isotyped to be ideal for multiplexing.
PrEST Antigen™ are recombinant protein fragments used as immunogens to generate Triple A Polyclonals™ antibodies and PrecisA Monoclonals™ antibodies. The PrEST Antigens are useful as control antigens, for example as blocking agents and positive assay controls together with the corresponding antibody.
The Human Protein Atlas
The open-access resource for human proteins
The Human Protein Atlas (HPA) is a unique world-leading effort to map all the proteins in cells, tissues, and organs in the human body using antibody-based imaging, mass spectrometry-based proteomics, transcriptomics, and systems biology.
HistoCyte Laboratories offers high quality, reproducible and cost-effective analyte control material for same-slide use in histopathology. Current products include controls for PD-L1, Her2, ER, PR, EML4-ALK, ROS1, NPM-ALK, HPV and p16.
evitria is an established, global antibody expression service provider located in Zurich, Switzerland. They specialize in CHO-based transient expression of antibodies - including bispecific and fusion antibodies - and other proteins.
Our Vision and Mission
Our vision is for every therapeutic discovery to be enhanced by our solutions.
Through our expertise and unique heritage, we provide innovative and high-quality solutions to researchers around the world.
By doing so we enable ground-breaking medical discovery, better diagnosis and patient outcomes.